EcoDrugPlus

Apelin Receptor 2

Ensembl ID : ENSLCRG00005012388
Gene Symbol: APLNR2
3 Cross references
171 Possible Orthologues:

Apoptosis Regulator Bcl-2-Like

Ensembl ID : ENSLCRG00005022687
Gene Symbol: LOC104939569
2 Cross references
168 Possible Orthologues:

Arachidonate 12-Lipoxygenase

Ensembl ID : ENSLCRG00005021450
Gene Symbol: ALOX12
3 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase A

Ensembl ID : ENSLCRG00005010486
Gene Symbol: ALOX5A
2 Cross references
225 Possible Orthologues:

Arginine Vasopressin Receptor 1a

Ensembl ID : ENSLCRG00005015403
Gene Symbol: AVPR1A
3 Cross references
195 Possible Orthologues:

Arginine Vasopressin Receptor 1aa

Ensembl ID : ENSLCRG00005005787
Gene Symbol: AVPR1AA
3 Cross references
170 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSLCRG00005007133
Gene Symbol: AVPR2
3 Cross references
178 Possible Orthologues:

Arginine Vasopressin Receptor 2

Ensembl ID : ENSLCRG00005009927
Gene Symbol: AVPR2
3 Cross references
148 Possible Orthologues:

Aromatase-Like

Ensembl ID : ENSLCRG00005016193
Gene Symbol: LOC104920192
3 Cross references
249 Possible Orthologues:

Atrial Natriuretic Peptide Receptor 2

Ensembl ID : ENSLCRG00005023727
Gene Symbol: LOC104922886
2 Cross references
185 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSLCRG00005021191
Gene Symbol: AURKA
3 Cross references
232 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSLCRG00005000498
Gene Symbol: AURKB
3 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).